Cargando…

Congenital hypothyroidism after newborn screening program reorganization in the Apulia region

BACKGROUND: Congenital hypothyroidism (CH) is the most frequent congenital endocrine disorder. The purpose of the present study was to evaluate the incidence and etiological classification of CH in Apulia in a three-year period according to the reorganization of the regional screening program in a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonetti, Simonetta, D’Amato, Gabriele, Esposito, Benedetta, Chiarito, Mariangela, Dentico, Domenico, Lorè, Tania, Cardinali, Roberta, Russo, Silvia, Laforgia, Nicola, Faienza, Maria Felicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335966/
https://www.ncbi.nlm.nih.gov/pubmed/35906638
http://dx.doi.org/10.1186/s13052-022-01328-0
_version_ 1784759446662021120
author Simonetti, Simonetta
D’Amato, Gabriele
Esposito, Benedetta
Chiarito, Mariangela
Dentico, Domenico
Lorè, Tania
Cardinali, Roberta
Russo, Silvia
Laforgia, Nicola
Faienza, Maria Felicia
author_facet Simonetti, Simonetta
D’Amato, Gabriele
Esposito, Benedetta
Chiarito, Mariangela
Dentico, Domenico
Lorè, Tania
Cardinali, Roberta
Russo, Silvia
Laforgia, Nicola
Faienza, Maria Felicia
author_sort Simonetti, Simonetta
collection PubMed
description BACKGROUND: Congenital hypothyroidism (CH) is the most frequent congenital endocrine disorder. The purpose of the present study was to evaluate the incidence and etiological classification of CH in Apulia in a three-year period according to the reorganization of the regional screening program in a single central laboratory, as well as to analyze the growth characteristics and the associated risk factors of the CH newborns diagnosed during the study period. METHODS: Data derived from the reorganization of the newborn screening program for CH in a single central laboratory that collects dried blood spot (DBS) from 27 Maternity Hospitals are analyzed over a three-year period. Birth weight and length, daily dose of L-T4 at specific key points (3, 6, 12 and 18 months, 2, 2.5 and 3 years) were also obtained from medical records of the CH newborns during the study period and calculated as standard deviation score (SDS). RESULTS: The screening program diagnosed 90 newborns with confirmed CH (incidence 1:990; recall rate: 3.6%). In detail, 75.6% newborns had an eutopic thyroid, and 24.4% had thyroid dysgenesis; 33 out of the 90 newborns (36.6%) had one or more risk factors. Among these, the multiple pregnancies are the most important because they tripled the risk of CH. At diagnosis, TSH levels were different between patients with dysgenesis and those with an eutopic thyroid (p = 0.005). Treatment was started at a mean of 18.5 ± 12.8 days of life. The mean starting dose of levothyroxine (L-T4) was 11.38 ± 2.46 μg/kg/day. CONCLUSIONS: The results of these study show an increase of CH cases in newborns with an eutopic thyroid compared to the traditional classification. The centralization of the screening program allows a closer cooperation between laboratory and clinical centers and facilitates the implementation of appropriate diagnostic evaluations and timely initiation of treatment, with positive effects on the management of the condition.
format Online
Article
Text
id pubmed-9335966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93359662022-07-30 Congenital hypothyroidism after newborn screening program reorganization in the Apulia region Simonetti, Simonetta D’Amato, Gabriele Esposito, Benedetta Chiarito, Mariangela Dentico, Domenico Lorè, Tania Cardinali, Roberta Russo, Silvia Laforgia, Nicola Faienza, Maria Felicia Ital J Pediatr Research BACKGROUND: Congenital hypothyroidism (CH) is the most frequent congenital endocrine disorder. The purpose of the present study was to evaluate the incidence and etiological classification of CH in Apulia in a three-year period according to the reorganization of the regional screening program in a single central laboratory, as well as to analyze the growth characteristics and the associated risk factors of the CH newborns diagnosed during the study period. METHODS: Data derived from the reorganization of the newborn screening program for CH in a single central laboratory that collects dried blood spot (DBS) from 27 Maternity Hospitals are analyzed over a three-year period. Birth weight and length, daily dose of L-T4 at specific key points (3, 6, 12 and 18 months, 2, 2.5 and 3 years) were also obtained from medical records of the CH newborns during the study period and calculated as standard deviation score (SDS). RESULTS: The screening program diagnosed 90 newborns with confirmed CH (incidence 1:990; recall rate: 3.6%). In detail, 75.6% newborns had an eutopic thyroid, and 24.4% had thyroid dysgenesis; 33 out of the 90 newborns (36.6%) had one or more risk factors. Among these, the multiple pregnancies are the most important because they tripled the risk of CH. At diagnosis, TSH levels were different between patients with dysgenesis and those with an eutopic thyroid (p = 0.005). Treatment was started at a mean of 18.5 ± 12.8 days of life. The mean starting dose of levothyroxine (L-T4) was 11.38 ± 2.46 μg/kg/day. CONCLUSIONS: The results of these study show an increase of CH cases in newborns with an eutopic thyroid compared to the traditional classification. The centralization of the screening program allows a closer cooperation between laboratory and clinical centers and facilitates the implementation of appropriate diagnostic evaluations and timely initiation of treatment, with positive effects on the management of the condition. BioMed Central 2022-07-29 /pmc/articles/PMC9335966/ /pubmed/35906638 http://dx.doi.org/10.1186/s13052-022-01328-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Simonetti, Simonetta
D’Amato, Gabriele
Esposito, Benedetta
Chiarito, Mariangela
Dentico, Domenico
Lorè, Tania
Cardinali, Roberta
Russo, Silvia
Laforgia, Nicola
Faienza, Maria Felicia
Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
title Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
title_full Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
title_fullStr Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
title_full_unstemmed Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
title_short Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
title_sort congenital hypothyroidism after newborn screening program reorganization in the apulia region
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335966/
https://www.ncbi.nlm.nih.gov/pubmed/35906638
http://dx.doi.org/10.1186/s13052-022-01328-0
work_keys_str_mv AT simonettisimonetta congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT damatogabriele congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT espositobenedetta congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT chiaritomariangela congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT denticodomenico congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT loretania congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT cardinaliroberta congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT russosilvia congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT laforgianicola congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion
AT faienzamariafelicia congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion